EDWARDS LIFESCIENCES CORP (EW)
US28176E1082 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 1.40B | 1.52B | 1.50B | 823.40M | 1.05B | |||
| Depreciation Amortization | 144.90M | 139.60M | 134.80M | 107.20M | 89.30M | |||
| Income Taxes - Deferred | -272.10M | -254.50M | -41.40M | -49.40M | 12.10M | |||
| Change In Working Capital | -526.30M | -421.40M | 145.30M | 42.20M | -204.30M | |||
| Interest Paid | 19.90M | 19.30M | 20.20M | 19.90M | 19.90M | |||
| Taxes Paid | 470.10M | 504.10M | 182.50M | 197.90M | 61.50M | |||
| Other non cash items | 149.90M | 232.60M | -9.70M | 130.90M | 235.40M | |||
| OPERATING CASH FLOW | 895.80M | 1.22B | 1.73B | 1.05B | 1.18B | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -266.30M | -264.80M | -329.80M | -407.30M | -278.40M | |||
| Other Investing Activity | 440.10M | 517.10M | -1.39B | -123.80M | -317.40M | |||
| INVESTING CASH FLOW | 173.80M | 252.30M | -1.72B | -531.10M | -595.80M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -300.00K | -200.00K | -1.80M | -800.00K | -10.00M | |||
| Stock Issued/Repurchased | -709.70M | -1.58B | -354.20M | -484.90M | -102.80M | |||
| Other Financing Activity | -1.00M | -3.60M | -300.00K | -1.20M | -2.80M | |||
| FINANCING CASH FLOW | -711.00M | -1.58B | -356.30M | -486.90M | -115.60M | |||
| Exchange Rate Effect | 16.80M | 19.20M | 13.90M | -20.50M | -3.00M | |||
| CHANGE IN CASH | 375.40M | -94.80M | -332.80M | 15.80M | 465.00M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 895.80M | 1.22B | 1.73B | 1.05B | 1.18B | |||
| Capital Expenditure | -266.30M | -264.80M | -329.80M | -407.30M | -278.40M | |||
| FREE CASH FLOW | 629.50M | 953.40M | 1.40B | 647.00M | 901.00M | |||
All data in USD